Ignite Creation Date:
2024-05-06 @ 7:13 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05934526
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-06-28
Brief Title:
Efficacy and Safety of Seralutinib in Adult Subjects With PAH PROSERA
Sponsor:
GB002 Inc
Organization:
Gossamer Bio Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-28
First Submit QC Date:
June 28 2023
Study First Post Date:
2023-07-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-20
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL